Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.37 for the 2020 fiscal year.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 10.98.

● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● Low profitability weakens the company.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The company is not the most generous with respect to shareholders' compensation.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● Analysts covering the stock have recently lowered their earnings forecast.

● For the last few months, analysts have been revising downwards their earnings forecast.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Below the resistance at 10.98 EUR, the stock shows a negative configuration when looking looking at the weekly chart.